{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T23:47:19Z","timestamp":1776124039548,"version":"3.50.1"},"reference-count":41,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,6,1]]},"abstract":"<jats:p>Objective. To describe the incidence, etiology, treatment, and outcome of newborns with total serum bilirubin (TSB) levels \u226530 mg\/dL (513 \u03bcmol\/L).<\/jats:p><jats:p>Design. Population-based case series.<\/jats:p><jats:p>Setting. Eleven Northern California Kaiser Permanente Medical Care Program hospitals and 1 affiliated hospital.<\/jats:p><jats:p>Patients. Eleven infants with TSB levels of \u226530 mg\/dL in the first 30 days after birth, identified using computer databases from a cohort of 111 009 infants born 1995\u20131998.<\/jats:p><jats:p>Outcome Measures. Clinical data from the birth hospitalization, rehospitalization, and outpatient visits in all infants; psychometric testing at age 5 (N = 3), neurologic examinations by child neurologists at age 5 (N = 3), or primary care providers (N = 7; mean age: 2.2 years); Parent Evaluation of Developmental Status (N = 8; mean age: 4.2 years).<\/jats:p><jats:p>Results. Maximum TSB levels of the 11 infants ranged from 30.7 to 45.5 mg\/dL (525 \u03bcmol\/L to 778 \u03bcmol\/L; mean: 34.9 mg\/dL [597 \u03bcmol\/L]). Four were born at 35 to 36 weeks gestation, and 7 were exclusively breastfed. Two had apparent isoimmunization; the etiology for the other 9 remained obscure, although only 4 were tested for glucose-6-phosphate dehydrogenase deficiency and 1 was bacteremic. None had acute neurologic symptoms. All received phototherapy and 5 received exchange transfusions. One infant died of sudden infant death syndrome; there was no kernicterus at autopsy. Two were lost to follow-up but were neurologically normal when last seen for checkups at 18 and 43 months. One child was receiving speech therapy at age 3. There were no significant parental concerns or abnormalities in the other children.<\/jats:p><jats:p>Conclusions. In this setting, TSB levels \u226530 mg\/dL were rare and generally unaccompanied by acute symptoms. Although we did not observe serious neurodevelopmental sequelae in this small sample, additional studies are required to quantify the known, significant risk of kernicterus in infants with very high TSB levels.<\/jats:p>","DOI":"10.1542\/peds.111.6.1303","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T00:43:47Z","timestamp":1092444227000},"page":"1303-1311","source":"Crossref","is-referenced-by-count":75,"title":["Infants With Bilirubin Levels of 30 mg\/dL or More in a Large Managed Care Organization"],"prefix":"10.1542","volume":"111","author":[{"given":"Thomas B.","family":"Newman","sequence":"first","affiliation":[{"name":"Departments of Epidemiology and Biostatistics"},{"name":"Pediatrics, School of Medicine, University of California, San Francisco, California"},{"name":"Division of Research, KPMCP, Oakland, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Liljestrand","sequence":"additional","affiliation":[{"name":"Departments of Epidemiology and Biostatistics"},{"name":"Division of Research, KPMCP, Oakland, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel J.","family":"Escobar","sequence":"additional","affiliation":[{"name":"Division of Research, KPMCP, Oakland, California"},{"name":"Department of Pediatrics, Kaiser Permanente Medical Center, Walnut Creek, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2003,6,1]]},"reference":[{"key":"2021120820220850600_R1","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia. Practice parameter: management of hyperbilirubinemia in the healthy term newborn. Pediatrics.1994;94:558\u2013565","DOI":"10.1542\/peds.94.4.558"},{"key":"2021120820220850600_R2","doi-asserted-by":"crossref","unstructured":"Newman TB, Escobar GJ, Gonzales V, Armstrong MA, Gardner M, Folck B. Frequency of neonatal bilirubin testing and hyperbilirubinemia in a large health maintenance organization. Pediatrics.1999;104:1198\u20131203","DOI":"10.1542\/peds.104.S6.1198"},{"key":"2021120820220850600_R3","doi-asserted-by":"crossref","unstructured":"Ebbesen F. Recurrence of kernicterus in term and near-term infants in Denmark. Acta Paediatr.2000;89:1213\u20131217","DOI":"10.1111\/j.1651-2227.2000.tb00738.x"},{"key":"2021120820220850600_R4","doi-asserted-by":"crossref","unstructured":"MacDonald M. Hidden risks: early discharge and bilirubin toxicity due to glucose-6-phosphate dehydrogenase deficiency. Pediatrics.1995;96:734\u2013738","DOI":"10.1542\/peds.96.4.734"},{"key":"2021120820220850600_R5","doi-asserted-by":"crossref","unstructured":"Washington EC, Ector W, Abboud M, Ohning B, Holden K. Hemolytic jaundice due to G6PD deficiency causing kernicterus in a female newborn. South Med J.1995;88:776\u2013779","DOI":"10.1097\/00007611-199507000-00019"},{"key":"2021120820220850600_R6","doi-asserted-by":"crossref","unstructured":"Stanley TV. A case of kernicterus in New Zealand: a predictable tragedy?J Paediatr Child Health.1997;33:451\u2013453","DOI":"10.1111\/j.1440-1754.1997.tb01641.x"},{"key":"2021120820220850600_R7","doi-asserted-by":"crossref","unstructured":"Penn AA, Enzmann DR, Hahn JS, Stevenson DK. Kernicterus in a full term infant. Pediatrics.1994;93:1003\u20131006","DOI":"10.1542\/peds.93.6.1003"},{"key":"2021120820220850600_R8","doi-asserted-by":"crossref","unstructured":"Harris MC, Bernbaum JC, Polin JR, Zimmerman R, Polin RA. Developmental follow-up of breastfed term and near-term infants with marked hyperbilirubinemia. Pediatrics.2001;107:1075\u20131080","DOI":"10.1542\/peds.107.5.1075"},{"key":"2021120820220850600_R9","unstructured":"The Psychological Corporation. Manual for the Wechsler Preschool and Primary Scale of Intelligence-Revised (1989). New York, NY: Harcourt Brace Jovanovich, Inc; 1989"},{"key":"2021120820220850600_R10","unstructured":"Beery K. The Beery-Buktenica Developmental test of Visual-Motor Integration 4th Edition, Revised (1997) Manual. Parsippany, NY: Modern Curriculum Press; 1997"},{"key":"2021120820220850600_R11","doi-asserted-by":"crossref","unstructured":"Gwynne K, Blick B, Hughes L. Use of an occupational therapy motor performance checklist by a school health service: a pilot study. J Paediatr Child Health.1996;32:386\u2013390","DOI":"10.1111\/j.1440-1754.1996.tb00935.x"},{"key":"2021120820220850600_R12","unstructured":"Achenbach T. Manual for the Child Behavior Checklist\/4\u201318 and 1991 Profile. Burlington, VT: University of Vermont, Department of Psychiatry; 1991"},{"key":"2021120820220850600_R13","doi-asserted-by":"crossref","unstructured":"Glascoe FP. Evidence-based approach to developmental and behavioural surveillance using parents\u2019 concerns. Child Care Health Dev.2000;26:137\u2013149","DOI":"10.1046\/j.1365-2214.2000.00173.x"},{"key":"2021120820220850600_R14","doi-asserted-by":"crossref","unstructured":"Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics.1999;103:6\u201314","DOI":"10.1542\/peds.103.1.6"},{"key":"2021120820220850600_R15","doi-asserted-by":"crossref","unstructured":"Atkinson LR, Escobar GJ, Takayama JI, Newman TB. Phototherapy use in jaundiced newborns in a large managed care organization: do physicians adhere to the guideline?Pediatrics.2003;111:e555\u2013e561","DOI":"10.1542\/peds.111.5.e555"},{"key":"2021120820220850600_R16","doi-asserted-by":"crossref","unstructured":"Newman TB, Xiong B, Gonzales VM, Escobar GJ. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med.2000;154:1140\u20131147","DOI":"10.1001\/archpedi.154.11.1140"},{"key":"2021120820220850600_R17","doi-asserted-by":"crossref","unstructured":"Newman TB, Easterling MJ. Yield of reticulocyte counts and blood smears in term infants. Clin Pediatr.1994;33:71\u201376","DOI":"10.1177\/000992289403300202"},{"key":"2021120820220850600_R18","doi-asserted-by":"crossref","unstructured":"Eberhard BA, Drew JH. Perhaps vigintiphobia should only apply to infants with Rhesus erythroblastosis. J Paediatr Child Health.1994;30:341\u2013344","DOI":"10.1111\/j.1440-1754.1994.tb00659.x"},{"key":"2021120820220850600_R19","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Committee on Fetus and Newborn. Hospital stay for healthy term newborns. Pediatrics.1995;96:788\u2013790","DOI":"10.1542\/peds.96.4.788"},{"key":"2021120820220850600_R20","doi-asserted-by":"crossref","unstructured":"Kramer LI. Advancement of dermal icterus in the jaundiced newborn. Am J Dis Child.1969;118:454\u2013458","DOI":"10.1001\/archpedi.1969.02100040456007"},{"key":"2021120820220850600_R21","doi-asserted-by":"crossref","unstructured":"Yetman RJ, Parks DK, Huseby V, Mistry K, Garcia J. Rebound bilirubin levels in infants receiving phototherapy. J Pediatr.1998;133:705\u2013707","DOI":"10.1016\/S0022-3476(98)70117-9"},{"key":"2021120820220850600_R22","doi-asserted-by":"crossref","unstructured":"Del Vecchio MT, Benstock MA, Sundel ER. Bilirubin rebound. J Pediatr.1999;135:531\u2013532","DOI":"10.1016\/S0022-3476(99)70186-1"},{"key":"2021120820220850600_R23","doi-asserted-by":"crossref","unstructured":"Lazar L, Litwin A, Merlob P. Phototherapy for neonatal nonhemolytic hyperbilirubinemia. Analysis of rebound and indications for discontinuing therapy. Clin Pediatr.1993;32:264\u2013267","DOI":"10.1177\/000992289303200502"},{"key":"2021120820220850600_R24","doi-asserted-by":"crossref","unstructured":"Davidson L, Merritt K, Weech A. Hyperbilirubinemia in the newborn. Am J Dis Child.1941;61:958\u2013980","DOI":"10.1001\/archpedi.1941.02000110046005"},{"key":"2021120820220850600_R25","doi-asserted-by":"crossref","unstructured":"Alpay F, Sarici SU, Tosuncuk HD, Serdar MA, Inanc N, Gokcay E. The value of first-day bilirubin measurement in predicting the development of significant hyperbilirubinemia in healthy term newborns. Pediatrics.2000;106(2). Available at: www.pediatrics.org\/cgi\/content\/full\/106\/2\/e16","DOI":"10.1542\/peds.106.2.e16"},{"key":"2021120820220850600_R26","doi-asserted-by":"crossref","unstructured":"Maisels MJ, Baltz RD, Bhutani VK, et al. Neonatal jaundice and kernicterus. Pediatrics.2001;108:763\u2013765","DOI":"10.1542\/peds.108.3.763"},{"key":"2021120820220850600_R27","doi-asserted-by":"crossref","unstructured":"Kramer MS, Demissie K, Yang H, Platt RW, Sauve R, Liston R. The contribution of mild and moderate preterm birth to infant mortality. Fetal and Infant Health Study Group of the Canadian Perinatal Surveillance System. JAMA.2000;284:843\u2013849","DOI":"10.1001\/jama.284.7.843"},{"key":"2021120820220850600_R28","doi-asserted-by":"crossref","unstructured":"Boyce TG, Mellen BG, Mitchel EF, Jr, Wright PF, Griffin MR. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid. J Pediatr.2000;137:865\u2013870","DOI":"10.1067\/mpd.2000.110531"},{"key":"2021120820220850600_R29","doi-asserted-by":"crossref","unstructured":"Cummins SK, Nelson KB, Grether JK, Velie EM. Cerebral palsy in four northern California counties, births 1983 through 1985. J Pediatr.1993;123:230\u2013237","DOI":"10.1016\/S0022-3476(05)81693-2"},{"key":"2021120820220850600_R30","doi-asserted-by":"crossref","unstructured":"Hagberg B, Hagberg G, Beckung E, Uvebrant P. Changing panorama of cerebral palsy in Sweden. VIII. Prevalence and origin in the birth year period 1991\u201394. Acta Paediatr.2001;90:271\u2013277","DOI":"10.1080\/080352501300067532"},{"key":"2021120820220850600_R31","doi-asserted-by":"crossref","unstructured":"Blair E, Stanley FJ. Cerebral palsy in low-birthweight infants: implications for perinatal care. Pediatr Perinat Epidemiol.1992;6:298\u2013310","DOI":"10.1111\/j.1365-3016.1992.tb00769.x"},{"key":"2021120820220850600_R32","unstructured":"McCormick MC, Shapiro S, Starfield BH. Rehospitalization in the first year of life for high-risk survivors. Pediatrics.1980;66:991\u2013999"},{"key":"2021120820220850600_R33","doi-asserted-by":"crossref","unstructured":"Niven GR, Harding JE. Another outcome of neonatal intensive care: first year mortality and hospital morbidity. J Paediatr Child Health.1995;31:137\u2013142","DOI":"10.1111\/j.1440-1754.1995.tb00763.x"},{"key":"2021120820220850600_R34","doi-asserted-by":"crossref","unstructured":"Cavalier S, Escobar GJ, Fernbach SA, Quesenberry CP, Jr, Chellino M. Postdischarge utilization of medical services by high-risk infants: experience in a large managed care organization. Pediatrics.1996;97:693\u2013699","DOI":"10.1542\/peds.97.5.693"},{"key":"2021120820220850600_R35","doi-asserted-by":"crossref","unstructured":"Escobar GJ, Joffe S, Gardner MN, Armstrong MA, Folck BF, Carpenter DM. Rehospitalization in the first two weeks after discharge from the neonatal intensive care unit. Pediatrics.1999;104(1). Available at: www.pediatrics.org\/cgi\/content\/full\/104\/1\/e2","DOI":"10.1542\/peds.104.1.e2"},{"key":"2021120820220850600_R36","unstructured":"Carpenter DM, Armstrong MA, Gardner MN, Folck F, Verdi JE, Escobar GJ. Rehospitalization in infants of 33\u201336 weeks\u2019 gestational age [abstract]. Pediatr Res.2000;47:304A"},{"key":"2021120820220850600_R37","doi-asserted-by":"crossref","unstructured":"Hansen TW. Acute management of extreme neonatal jaundice\u2013the potential benefits of intensified phototherapy and interruption of enterohepatic bilirubin circulation. Acta Paediatr.1997;86:843\u2013846","DOI":"10.1111\/j.1651-2227.1997.tb08608.x"},{"key":"2021120820220850600_R38","unstructured":"Mores A, Fargasova I, Minarikova E. The relation of hyperbilirubinemia in the newborn without isoimmunization to kernicterus. Acta Paediatr.1959;48:590\u2013602"},{"key":"2021120820220850600_R39","doi-asserted-by":"crossref","unstructured":"Maisels M, Newman T. Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics.1995;96:730\u2013736","DOI":"10.1542\/peds.96.4.730"},{"key":"2021120820220850600_R40","doi-asserted-by":"crossref","unstructured":"Johnson LH, Bhutani VK, Brown AK. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr.2002;140:396\u2013403","DOI":"10.1067\/mpd.2002.123098"},{"key":"2021120820220850600_R41","doi-asserted-by":"crossref","unstructured":"Classen DC, Pestotnik SL, Evans RS, Burke JP. Computerized surveillance of adverse drug events in hospital patients. JAMA.1991;266:2847\u20132851","DOI":"10.1001\/jama.266.20.2847"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/111\/6\/1303\/1010900\/pe0603001303.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/111\/6\/1303\/1010900\/pe0603001303.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T05:40:53Z","timestamp":1682746853000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/111\/6\/1303\/28607\/Infants-With-Bilirubin-Levels-of-30-mg-dL-or-More"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6,1]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2003,6,1]]},"published-print":{"date-parts":[[2003,6,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.111.6.1303","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6,1]]}}}